Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
6th grade Good
|
Filing tables
Filing exhibits
VAXX similar filings
Filing view
External links
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333- 273822)
and Form S-8 (Nos. 333-271486 and 333-261061) of Vaxxinity, Inc. (the "Company") of our report dated
March 27, 2024, with respect to the consolidated financial statements of the Company included in this
Annual Report on Form 10-K for the year ended December 31, 2023. Our report contains an explanatory
paragraph describing conditions that raise substantial doubt about the Company's ability to continue as a
going concern. The consolidated financial statements do not include any adjustments that might result from
the outcome of this uncertainty.
/s/ FORVIS, LLP
New York, New York
March 27, 2024